We are live on
!
Find out more
GC
Gratry & Company Portfolio holdings
AUM
$72.2M
1-Year Est. Return
19.87%
This Fund
S&P 500
This Quarter
Est. Return
+3.41%
1 Year Est. Return
+19.87%
3 Year Est. Return
+44.17%
5 Year Est. Return
+89.51%
10 Year Est. Return
–
AUM
$254M
AUM Growth
-$23.7M
(-8.5%)
Cap. Flow
-$30.5M
Cap. Flow
% of AUM
-11.99%
Top 10 Holdings %
Top 10 Hldgs %
34.9%
Holding
66
New
3
Increased
5
Reduced
51
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLB Ltd
SLB
|
+$7.41M |
| 2 |
Prudential
PUK
|
+$5.42M |
| 3 |
Banco Santander
SAN
|
+$1.43M |
| 4 |
GMK
GRUMA SAB DE C V ADS(RP 4 B SHS
GMK
|
+$173K |
| 5 |
Ericsson
ERIC
|
+$126K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$8.11M |
| 2 |
AZ
Allianz Se Sponsored Adr Repstg 1/10 Ord Sh
AZ
|
+$7.41M |
| 3 |
Sumitomo Mitsui Financial
SMFG
|
+$6.24M |
| 4 |
WX
WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX
|
+$3.78M |
| 5 |
NXP Semiconductors
NXPI
|
+$1.85M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.25% |
| 2 | Industrials | 12.47% |
| 3 | Financials | 10.02% |
| 4 | Consumer Discretionary | 9.27% |
| 5 | Technology | 8.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
JPMorgan Chase
JPM
$939B
| $329K | 0.13% |
5,715
| – | – |
|
52
3M
MMM
$89B
| $275K | 0.11% |
2,296
-90
| -4% | -$10.6K |
|
|
GMK
53
DELISTED
GRUMA SAB DE C V ADS(RP 4 B SHS
GMK
| $210K | 0.08% |
+4,385
| New | +$173K |
|
|
54
Sumitomo Mitsui Financial
SMFG
$166B
| – | – |
-721,020
| Closed | -$6.24M |
|
|
AZ
55
DELISTED
Allianz Se Sponsored Adr Repstg 1/10 Ord Sh
AZ
| – | – |
-439,820
| Closed | -$7.41M |
|
|
COV
56
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
| – | – |
-110,117
| Closed | -$8.11M |
|
Similar funds
T
DCM
XS
BSCP
SCM
FMA
MSTVIM
LA
Gratry & Company's Q2 2014 Portfolio in Review
As of Q2 2014, Gratry & Company held 66 positions worth $254M, down 8.5% from $278M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Gratry & Company withdrew a net $30.5M in Q2 2014, closing 3 positions and reducing 51 holdings. Its most notable exit was COVIDIEN PLC COM SHS NEW (IRELAND), an estimated $8.11M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 21% a quarter earlier, followed by Industrials and Financials.
Against the trend, Gratry & Company opened a new position in SLB Ltd worth $8.48M.
- Gratry & Company's largest Q2 2014 buy was SLB Ltd: 71,920 shares worth $8.48M.
- Gratry & Company added most to Prudential in Q2 2014, an estimated $5.42M increase.
- Gratry & Company's biggest Q2 2014 reduction was WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS, cutting an estimated $3.78M.
- Gratry & Company fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q2 2014, selling an estimated $8.11M.
- Gratry & Company's ten largest holdings make up 35% of its $254M portfolio in Q2 2014.
- Gratry & Company opened 3 new positions and closed 3 in Q2 2014.
- Gratry & Company's portfolio value fell 8.5% quarter-over-quarter to $254M.
Based on Gratry & Company's 13F filing for Q2 2014, filed 31 Jul 2014.